The biotech companies DARA BioSciences and America Stem Cell announce their collaboration in adult stem cell research for the treatment of hematological disorders.
The adult stem cell company Osiris Therapeutics today announced the achievement of a milestone payment in the progress of its adult stem cell therapy for the treatment of Type I diabetes.
Once again, veterinary stem cell therapies are in the news for their consistent success.
A review of recent, and not-so-recent, advances in stem cell science reveal that any clinical applications of embryonic stem cell research are still decades away.
Following the success obtained in other countries with the same procedure, doctors in Spain are using adult stem cells to treat patients with Crohn's disease.
Pluristem Therapeutics has announced filing of applications with both the U.S. and European regulatory agencies to initiate clinical trials in the treatment of critical limb ischemia with adult stem cells.
Adult Stem Cells Show Positive Results in the Treatment of Autoimmune, Vascular and Cardiac Diseases
A review of the medical literature yields positive conclusions for the clinical use of adult stem cells in the treatment of some of the most serious of diseases.
With the potential to have great impact on individuals who suffer from Myasthenia Gravis, an extremely rare bone marrow transplant has been performed by doctors at The Bone Marrow Transplant Program at University of California, San Diego Medical Center. This is the first time the operation has been attempted by any hospital in the western part of the United States.
The market for stem cell treatement is perfectly positioned to explode.
Juvenile diabetes is an incurable disease, but stem cell treatment is proving to be effective in treating this condition.